| Epigenetic Modifications of c-MYC: Role in Cancer Cell Reprogramming, Progression and Chemoresistance H Fatma, S Maurya, HR Siddique Seminars in cancer biology, 2020 | 63 | 2020 |
| Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease … SK Maurya, AK Maurya, N Mishra, H Siddique Journal of Receptors and Signal Transduction 40 (6), 605-612, 2020 | 52 | 2020 |
| Mechanochemical Synthesis of Sulfur Quantum Dots for Cellular Imaging F Arshad, S Md Palashuddin, SK Maurya, HR Siddique ACS Applied Nano Materials 4 (4), 3339–3344, 2021 | 35 | 2021 |
| Bulbine frutescens phytochemicals as novel ABC-transporter inhibitor: a molecular docking and molecular dynamics simulation study PP Kushwaha, SK Maurya, A Singh, SK Prajapati, AK Singh, S Mohd, ... Journal of Cancer Metastasis and Treatment 7 (2), 2021 | 23 | 2021 |
| Chemosensitization of therapy resistant tumors: targeting multiple cell signaling pathways by Lupeol, a pentacyclic triterpene SK Maurya, G Shadab, HR Siddique Current Pharmaceutical Design 26 (4), 455-465, 2020 | 23 | 2020 |
| New Tailored RNA-Targeted Organometallic Drug Candidates against Huh7 (Liver) and Du145 (Prostate) Cancer Cell Lines HY Khan, SK Maurya, HR Siddique, S Yousuf, A Farukh* ACS omega 5 (25), 5218–15228, 2020 | 16 | 2020 |
| Inhibition of multidrug resistance property of Candida albicans by natural compounds of parthenium hysterophorus L. An In- Silico approach AK Verma, SK Maurya, A Kumar, M Barik, V Yadav, B Umar, M Lawal, ... Journal of Pharmacognosy and Phytochemistry 9 (3), 55-64, 2020 | 16 | 2020 |
| Antiandrogen Enzalutamide Induced Genetic, Cellular, and Hepatic Damages: Amelioration by Triterpene Lupeol. AK Mohammad, D Singh, H Fatma, K Akhtar, F Arjmand, SK Maurya, ... Drug and Chemical Toxicology 45 (1), 1-12, 2022 | 14* | 2022 |
| The multiple faces of NANOG in cancer: a therapeutic target to chemosensitize therapy-resistant cancers H Fatma, HR Siddique, S Maurya Epigenomics 13 (2), 2021 | 12 | 2021 |
| Bulbine frutescens Phytochemicals as a Promising Anti-cancer Drug Discovery Source: A Computational Study PP Kushwaha, A Kumar, SK Maurya, AK Singh, AK Sharma, S Kumar Phytochemistry: An in-silico and in-vitro Update, C1-C1, 2019 | 8 | 2019 |
| Withania somnifera phytochemicals possess SARS-CoV-2 RdRp and human TMPRSS2 protein binding potential S Prajapati, AK Singh, KushwahaPP, S Mohd, SK Maurya, S Gupta, ... Vegetos, 2022 | 7 | 2022 |
| Toxicity of Heavy Metals on Health and their Microbial Remediation in Environment RK Gupta, D Panchal, SV Pothabathula, PP Kushwaha, S Maurya, ... | 7 | 2019 |
| Role of lupeol in chemosensitizing therapy-resistant prostate cancer cells by targeting MYC, β-catenin and c-FLIP: in silico and in vitro studies M SK, H Fatma, M AK, M N, S H in silico pharmacology 10 (16), 2022 | 4 | 2022 |
| Phytochemicals, cancer and miRNAs: an in-silico approach N Kashyap, PP Kushwaha, AK Singh, S Maurya, AK Sahoo, S Kumar Phytochemistry: An in-silico and in-vitro Update: Advances in Phytochemical …, 2019 | 4 | 2019 |
| Neolamarckia cadamba (Roxb.) Bosser (Rubiaceae) extracts: promising prospects for anticancer and antibacterial potential through in vitro and in silico studies A Mishra, SK Maurya, H Singh, Anirudh, Siddique, SK Samanta, N Mishra Medical Oncology, 1-13, 2023 | 3 | 2023 |
| Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy AK Mohammad, D Singh, M Jammel, SK Maurya, S Swati, K Akhtar, ... Toxicology and Applied Pharmacology, 2023 | 1 | 2023 |
| Repurposing FDA-approved anti-diabetic drug to target H. pylori peptidyl deformylase using computer-based drug discovery approach AK Singh, SK Maurya, S Kumar Molecular Simulation, 2022 | 1 | 2022 |
| Novel Terpenoids as Anticancer Stem Cell Agents R Malik, SK Maurya, PP Kushwaha, P Singh, S Kumar Phytochemistry 3, 393-420, 2018 | 1 | 2018 |
| Lupeol chemosensitize the cancer stem cells for enzalutamide and ameliorate the enzalutamide induced toxicity in prostate cancer H Siddique, S Maurya Cancer res (supplement) AACR Annual Meeting 2021 81 (13), 2021 | | 2021 |
| Bacterial Cell Culture AK Sharma, SK Maurya, S Kumar Clinical Biochemistry and Drug Development, 33-42, 2020 | | 2020 |
Dr. Hifzur R Siddique, FBRS, MNAScAligarh Muslim UniversityVerified email at amu.ac.in
